Characterization of recombinant human epidermal growth factor produced in yeast. 1988

C George-Nascimento, and A Gyenes, and S M Halloran, and J Merryweather, and P Valenzuela, and K S Steimer, and F R Masiarz, and A Randolph
Chiron Research Laboratories, Chiron Corporation, Emeryville, California 94608.

Four different forms of human epidermal growth factor (h-EGF) are found in the culture medium of a recombinant strain of Saccharomyces cerevisiae. These forms were characterized after purification using reverse-phase high-performance liquid chromatography. The most abundant form of secreted recombinant h-EGF has leucine at the carboxyl terminus and is identical with gamma-urogastrone. A second species is identical with the most abundant form except that it lacks the carboxyl-terminal leucine. This form appears to be the product of a carboxypeptidase found in the growth medium. The other two forms of recombinant h-EGF are the respective oxidation products of the above where the single methionine residue has been converted to methionine sulfoxide. These four forms of recombinant h-EGF are fully active; they bind to the EGF receptor of A431 cells as well as stimulate mitotic activity of human foreskin fibroblasts with equal specific activity. The location of the disulfide bonds in the predominant form of recombinant h-EGF was determined following digestion with thermolysin. The amino acid compositions of the resulting peptides showed that the placement of disulfide bonds in recombinant h-EGF is identical with that in murine EGF.

UI MeSH Term Description Entries
D008297 Male Males
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003488 Cyanogen Bromide Cyanogen bromide (CNBr). A compound used in molecular biology to digest some proteins and as a coupling reagent for phosphoroamidate or pyrophosphate internucleotide bonds in DNA duplexes. Bromide, Cyanogen
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C George-Nascimento, and A Gyenes, and S M Halloran, and J Merryweather, and P Valenzuela, and K S Steimer, and F R Masiarz, and A Randolph
January 2013, Advanced pharmaceutical bulletin,
C George-Nascimento, and A Gyenes, and S M Halloran, and J Merryweather, and P Valenzuela, and K S Steimer, and F R Masiarz, and A Randolph
June 1992, The Journal of biological chemistry,
C George-Nascimento, and A Gyenes, and S M Halloran, and J Merryweather, and P Valenzuela, and K S Steimer, and F R Masiarz, and A Randolph
February 2002, Protein expression and purification,
C George-Nascimento, and A Gyenes, and S M Halloran, and J Merryweather, and P Valenzuela, and K S Steimer, and F R Masiarz, and A Randolph
January 1992, Japanese journal of ophthalmology,
C George-Nascimento, and A Gyenes, and S M Halloran, and J Merryweather, and P Valenzuela, and K S Steimer, and F R Masiarz, and A Randolph
June 1988, Gene,
C George-Nascimento, and A Gyenes, and S M Halloran, and J Merryweather, and P Valenzuela, and K S Steimer, and F R Masiarz, and A Randolph
January 2017, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology],
C George-Nascimento, and A Gyenes, and S M Halloran, and J Merryweather, and P Valenzuela, and K S Steimer, and F R Masiarz, and A Randolph
February 1989, Chemical & pharmaceutical bulletin,
C George-Nascimento, and A Gyenes, and S M Halloran, and J Merryweather, and P Valenzuela, and K S Steimer, and F R Masiarz, and A Randolph
June 1990, Molecular endocrinology (Baltimore, Md.),
C George-Nascimento, and A Gyenes, and S M Halloran, and J Merryweather, and P Valenzuela, and K S Steimer, and F R Masiarz, and A Randolph
September 1997, The Biochemical journal,
C George-Nascimento, and A Gyenes, and S M Halloran, and J Merryweather, and P Valenzuela, and K S Steimer, and F R Masiarz, and A Randolph
December 2020, Biotechnology reports (Amsterdam, Netherlands),
Copied contents to your clipboard!